Overview

Phase 3 Efficacy and Safety of VVZ-149 Injections for Postoperative Pain Following Laparoscopic Colectomy

Status:
Completed
Trial end date:
2022-11-22
Target enrollment:
Participant gender:
Summary
The purpose of this phase 3 study is to evaluate the efficacy and safety of VVZ-149 Injections for the treatment of postoperative pain following laparoscopic colectomy.
Phase:
Phase 3
Details
Lead Sponsor:
Vivozon Pharmaceutical Inc.